Literature DB >> 9236901

Cellular proliferation characteristics of basal cell carcinoma: relationship to clinical subtype and histopathology.

N M Horlock1, G D Wilson, F M Daley, P I Richman, R Sanders.   

Abstract

This study investigates the proliferation characteristics of 81 primary basal cell carcinomas (BCC) using detection of the Ki-67 antigen by immunohistochemistry. The tumours were classified into distinct sub-types based on their histological growth pattern and differentiation status. The mean Ki-67 growth fraction was 0.293 and this was found to vary between the different growth patterns, with morpheic, infiltrating and superficial tumours showing the highest levels of proliferation at 0.373, 0.351 and 0.335, respectively; the nodular and micronodular growth patterns were significantly lower at 0.248 and 0.232, respectively. No overall association was seen between proliferation and differentiation status although certain histological growth patterns such as nodular showed a greater propensity to differentiate. Proliferation was related to tumour size, with larger lesions exhibiting higher growth fractions although this may have also been related to tumour subtype as infiltrating and morpheic tumours tended to present with larger tumour diameters. The spatial distribution of proliferating cells by Ki-67 labelling was not related to tumour subtype, differentiation or growth fraction. These studies have shown BCC to possess proliferative characteristics akin to other solid tumours commonly regarded as more rapidly dividing. There was an association between growth fraction and tumour subtype consistent with higher proliferation in the lesions considered to be more aggressive.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236901     DOI: 10.1016/s0748-7983(97)92508-7

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Novel Methacrylate-Based Multilayer Nanofilms with Incorporated FePt-Based Nanoparticles and the Anticancer Drug 5-Fluorouracil for Skin Cancer Treatment.

Authors:  Kristijan Skok; Tanja Zidarič; Kristjan Orthaber; Matevž Pristovnik; Nina Kostevšek; Kristina Žužek Rožman; Sašo Šturm; Lidija Gradišnik; Uroš Maver; Tina Maver
Journal:  Pharmaceutics       Date:  2022-03-22       Impact factor: 6.525

2.  Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases.

Authors:  Xuhui Ma; Yunteng Wu; Tian Zhang; Hao Song; Houyu Jv; Wei Guo; Guoxin Ren
Journal:  J Cancer       Date:  2017-10-17       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.